Hangzhou Zhiwei Information Technology Co., Ltd. (Morphogo) focuses on innovation in intelligent diagnostic technologies for cytopathology and is committed to providing advanced artificial intelligence solutions for the global healthcare industry. For over a decade, the company has been deeply engaged in bone marrow cell morphology diagnostics and has built a full-stack proprietary technology system encompassing ultra-high-resolution whole-slide digital imaging, intelligent cell segmentation and classification, multimodal data fusion diagnostics, and interpretable report generation. Its self-developed Morphogo System has reached an internationally leading level, with more than 40 granted patents and medical certifications from China, the EU and multiple other countries. Upholding the mission of “Transforming Medical Testing with Artificial Intelligence,” Morphogo is dedicated to driving the digital transformation of cytology. By leveraging AI, the company is redefining efficiency and standards in cytological diagnostics and leading the field toward a new era of automation, standardization, digitalization, and intelligence.